VR ADVISER, LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, VR ADVISER, LLC held in its portfolio 27 assets valued at $2,024,517,832 (i.e. $2.03B).

The most valuable assets in the portfolio included: APOGEE THERAPEUTICS INC ($641.08M), ORUKA THERAPEUTICS INC ($125.74M), and VIRIDIAN THERAPEUTICS INC ($120.83M).

The chart below shows the top 10 valuable assets, and the table below shows the top 27 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.
Data Source: SEC.
Top Valuable Stocks in VR ADVISER, LLC Portfolio
APOGEE THERAPEUTICS INC
ORUKA THERAPEUTICS INC
VIRIDIAN THERAPEUTICS INC
SPYRE THERAPEUTICS INC
KALVISTA PHARMACEUTICALS INC
OCULAR THERAPEUTIX INC
SAVARA INC
COGENT BIOSCIENCES INC
ERASCA INC
CYTOMX THERAPEUTICS INC
VR ADVISER, LLC - Stock Holdings in 13F Filings (SEC)
Items per page:
0 of 0
Name of Issuer No. of Shares Value ($) Class
APOGEE THERAPEUTICS INC 8493321 641075869 COM
ORUKA THERAPEUTICS INC 4148428 125738853 COM
VIRIDIAN THERAPEUTICS INC 3882709 120829904 COM
SPYRE THERAPEUTICS INC 3685448 120735276 COM NEW
KALVISTA PHARMACEUTICALS INC 6728985 108673108 COM
OCULAR THERAPEUTIX INC 7315547 88810741 COM
SAVARA INC 13740375 82854461 COM
COGENT BIOSCIENCES INC 2000000 71040000 COM
ERASCA INC 17857083 66428349 COM
CYTOMX THERAPEUTICS INC 15561500 66291990 COM
MAZE THERAPEUTICS INC 1548569 64157214 COM
JADE BIOSCIENCES INC 3220364 49690217 COM NEW
ENLIVEN THERAPEUTICS INC 3226331 49685497 COM
ORIC PHARMACEUTICALS INC 5676230 46431561 COM
ENGENE HOLDINGS INC 4771414 43085868 COM
DYNE THERAPEUTICS INC 2173913 42521738 COM
DIANTHUS THERAPEUTICS INC 1000000 41210000 COM
UPSTREAM BIO INC 1169298 31746441 COM
CYBIN INC 3840250 31413245 COM NEW
ZURA BIO LTD 5345115 28008403 CLASS A ORD SHS
VOR BIOPHARMA INC 1943766 25424459 COM NEW
CRESCENT BIOPHARMA INC. 2133576 25304211 COM
SEPTERNA INC 610808 17029327 COM
SURROZEN INC 632931 14304241 COM NEW
CULLINAN THERAPEUTICS INC 1379965 14282638 COM
ARTIVA BIOTHERAPEUTICS INC 1609569 6905051 COM
CASI PHARMACEUTICALS INC 987259 839170 ORD SHS